0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Swine Vaccines- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Published Date: August 2025
|
Report Code: QYRE-Auto-6J9176
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Swine Vaccines Market Outlook 2022
BUY CHAPTERS

Swine Vaccines- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Code: QYRE-Auto-6J9176
Report
August 2025
Pages:138
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Swine Vaccines- Market Size

The global market for Swine Vaccines was estimated to be worth US$ 1491 million in 2024 and is forecast to a readjusted size of US$ 1954 million by 2031 with a CAGR of 4.0% during the forecast period 2025-2031.

Swine Vaccines- Market

Swine Vaccines- Market

The immune system responds by producing antibodies that destroy the infectious agents, usually in co-operation with specialised body cells or by neutralising the toxins that are responsible for the disease. This process of stimulating immunity is called vaccination.
Vaccines contain antigens from viruses, bacteria, bacterial toxins, or parasites. They are given to pigs, usually by injection, to stimulate an immune response which will protect the pigs against later natural infection with the organism from which the vaccine was derived. Most stimulate both a humoral response and a cell-mediated response.
Vaccines can either contain viable organisms that will multiply in the pig, or inactivated ones that will not multiply in the pig.
China is the largest region of Swine Vaccines, with a share more than 40%, followed by Europe and North America, etc. Merck, Boehringer Ingelheim, Jinyu Bio-Technology, CAHIC and Tecon are the top 5 manufacturers of industry, and they had a more than 55% combined market share.
This report aims to provide a comprehensive presentation of the global market for Swine Vaccines, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Swine Vaccines by region & country, by Type, and by Application.
The Swine Vaccines market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Swine Vaccines.
Market Segmentation

Scope of Swine Vaccines- Market Report

Report Metric Details
Report Name Swine Vaccines- Market
Forecasted market size in 2031 US$ 1954 million
CAGR 4.0%
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Government Tender
  • Market Sales
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Merck, Boehringer Ingelheim, Jinyu Bio-Technology, CAHIC, Tecon, Zoetis, Ceva, Hile Bio, Chopper Biology, WINSUN, Hipra, Ringpu Biology, ChengDu Tecbond, DHN, CAVAC, Virbac, HVRI, Bioveta
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Swine Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Swine Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Swine Vaccines in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Swine Vaccines- Market size in 2031?

Ans: The Swine Vaccines- Market size in 2031 will be US$ 1954 million.

What is the Swine Vaccines- Market share by region?

Ans: China is the largest region of Swine Vaccines, with a share more than 40%, followed by Europe and North America, etc.

What is the market share of major companies in Swine Vaccines- Market?

Ans: Merck, Boehringer Ingelheim, Jinyu Bio-Technology, CAHIC and Tecon are the top 5 manufacturers of industry, and they had a more than 55% combined market share.

Who are the main players in the Swine Vaccines- Market report?

Ans: The main players in the Swine Vaccines- Market are Merck, Boehringer Ingelheim, Jinyu Bio-Technology, CAHIC, Tecon, Zoetis, Ceva, Hile Bio, Chopper Biology, WINSUN, Hipra, Ringpu Biology, ChengDu Tecbond, DHN, CAVAC, Virbac, HVRI, Bioveta

What are the Application segmentation covered in the Swine Vaccines- Market report?

Ans: The Applications covered in the Swine Vaccines- Market report are Government Tender, Market Sales

What are the Type segmentation covered in the Swine Vaccines- Market report?

Ans: The Types covered in the Swine Vaccines- Market report are CSF Vaccines, FMD Vaccines, Porcine Circovirus Vaccines, PRRS Vaccines, Others

Recommended Reports

Animal Disease Vaccines

Genetic Engineering Vaccines

Flu and Viral Vaccines

1 Market Overview
1.1 Swine Vaccines Product Introduction
1.2 Global Swine Vaccines Market Size Forecast
1.2.1 Global Swine Vaccines Sales Value (2020-2031)
1.2.2 Global Swine Vaccines Sales Volume (2020-2031)
1.2.3 Global Swine Vaccines Sales Price (2020-2031)
1.3 Swine Vaccines Market Trends & Drivers
1.3.1 Swine Vaccines Industry Trends
1.3.2 Swine Vaccines Market Drivers & Opportunity
1.3.3 Swine Vaccines Market Challenges
1.3.4 Swine Vaccines Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Swine Vaccines Players Revenue Ranking (2024)
2.2 Global Swine Vaccines Revenue by Company (2020-2025)
2.3 Global Swine Vaccines Players Sales Volume Ranking (2024)
2.4 Global Swine Vaccines Sales Volume by Company Players (2020-2025)
2.5 Global Swine Vaccines Average Price by Company (2020-2025)
2.6 Key Manufacturers Swine Vaccines Manufacturing Base and Headquarters
2.7 Key Manufacturers Swine Vaccines Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Swine Vaccines
2.9 Swine Vaccines Market Competitive Analysis
2.9.1 Swine Vaccines Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Swine Vaccines Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Swine Vaccines as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 CSF Vaccines
3.1.2 FMD Vaccines
3.1.3 Porcine Circovirus Vaccines
3.1.4 PRRS Vaccines
3.1.5 Others
3.2 Global Swine Vaccines Sales Value by Type
3.2.1 Global Swine Vaccines Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Swine Vaccines Sales Value, by Type (2020-2031)
3.2.3 Global Swine Vaccines Sales Value, by Type (%) (2020-2031)
3.3 Global Swine Vaccines Sales Volume by Type
3.3.1 Global Swine Vaccines Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Swine Vaccines Sales Volume, by Type (2020-2031)
3.3.3 Global Swine Vaccines Sales Volume, by Type (%) (2020-2031)
3.4 Global Swine Vaccines Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Government Tender
4.1.2 Market Sales
4.2 Global Swine Vaccines Sales Value by Application
4.2.1 Global Swine Vaccines Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Swine Vaccines Sales Value, by Application (2020-2031)
4.2.3 Global Swine Vaccines Sales Value, by Application (%) (2020-2031)
4.3 Global Swine Vaccines Sales Volume by Application
4.3.1 Global Swine Vaccines Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Swine Vaccines Sales Volume, by Application (2020-2031)
4.3.3 Global Swine Vaccines Sales Volume, by Application (%) (2020-2031)
4.4 Global Swine Vaccines Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Swine Vaccines Sales Value by Region
5.1.1 Global Swine Vaccines Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Swine Vaccines Sales Value by Region (2020-2025)
5.1.3 Global Swine Vaccines Sales Value by Region (2026-2031)
5.1.4 Global Swine Vaccines Sales Value by Region (%), (2020-2031)
5.2 Global Swine Vaccines Sales Volume by Region
5.2.1 Global Swine Vaccines Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Swine Vaccines Sales Volume by Region (2020-2025)
5.2.3 Global Swine Vaccines Sales Volume by Region (2026-2031)
5.2.4 Global Swine Vaccines Sales Volume by Region (%), (2020-2031)
5.3 Global Swine Vaccines Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Swine Vaccines Sales Value, 2020-2031
5.4.2 North America Swine Vaccines Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Swine Vaccines Sales Value, 2020-2031
5.5.2 Europe Swine Vaccines Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Swine Vaccines Sales Value, 2020-2031
5.6.2 Asia Pacific Swine Vaccines Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Swine Vaccines Sales Value, 2020-2031
5.7.2 South America Swine Vaccines Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Swine Vaccines Sales Value, 2020-2031
5.8.2 Middle East & Africa Swine Vaccines Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Swine Vaccines Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Swine Vaccines Sales Value
6.2.1 Key Countries/Regions Swine Vaccines Sales Value, 2020-2031
6.2.2 Key Countries/Regions Swine Vaccines Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Swine Vaccines Sales Value, 2020-2031
6.3.2 United States Swine Vaccines Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Swine Vaccines Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Swine Vaccines Sales Value, 2020-2031
6.4.2 Europe Swine Vaccines Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Swine Vaccines Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Swine Vaccines Sales Value, 2020-2031
6.5.2 China Swine Vaccines Sales Value by Type (%), 2024 VS 2031
6.5.3 China Swine Vaccines Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Swine Vaccines Sales Value, 2020-2031
6.6.2 Japan Swine Vaccines Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Swine Vaccines Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Swine Vaccines Sales Value, 2020-2031
6.7.2 South Korea Swine Vaccines Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Swine Vaccines Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Swine Vaccines Sales Value, 2020-2031
6.8.2 Southeast Asia Swine Vaccines Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Swine Vaccines Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Swine Vaccines Sales Value, 2020-2031
6.9.2 India Swine Vaccines Sales Value by Type (%), 2024 VS 2031
6.9.3 India Swine Vaccines Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Merck
7.1.1 Merck Company Information
7.1.2 Merck Introduction and Business Overview
7.1.3 Merck Swine Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Merck Swine Vaccines Product Offerings
7.1.5 Merck Recent Development
7.2 Boehringer Ingelheim
7.2.1 Boehringer Ingelheim Company Information
7.2.2 Boehringer Ingelheim Introduction and Business Overview
7.2.3 Boehringer Ingelheim Swine Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Boehringer Ingelheim Swine Vaccines Product Offerings
7.2.5 Boehringer Ingelheim Recent Development
7.3 Jinyu Bio-Technology
7.3.1 Jinyu Bio-Technology Company Information
7.3.2 Jinyu Bio-Technology Introduction and Business Overview
7.3.3 Jinyu Bio-Technology Swine Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Jinyu Bio-Technology Swine Vaccines Product Offerings
7.3.5 Jinyu Bio-Technology Recent Development
7.4 CAHIC
7.4.1 CAHIC Company Information
7.4.2 CAHIC Introduction and Business Overview
7.4.3 CAHIC Swine Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 CAHIC Swine Vaccines Product Offerings
7.4.5 CAHIC Recent Development
7.5 Tecon
7.5.1 Tecon Company Information
7.5.2 Tecon Introduction and Business Overview
7.5.3 Tecon Swine Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Tecon Swine Vaccines Product Offerings
7.5.5 Tecon Recent Development
7.6 Zoetis
7.6.1 Zoetis Company Information
7.6.2 Zoetis Introduction and Business Overview
7.6.3 Zoetis Swine Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Zoetis Swine Vaccines Product Offerings
7.6.5 Zoetis Recent Development
7.7 Ceva
7.7.1 Ceva Company Information
7.7.2 Ceva Introduction and Business Overview
7.7.3 Ceva Swine Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Ceva Swine Vaccines Product Offerings
7.7.5 Ceva Recent Development
7.8 Hile Bio
7.8.1 Hile Bio Company Information
7.8.2 Hile Bio Introduction and Business Overview
7.8.3 Hile Bio Swine Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Hile Bio Swine Vaccines Product Offerings
7.8.5 Hile Bio Recent Development
7.9 Chopper Biology
7.9.1 Chopper Biology Company Information
7.9.2 Chopper Biology Introduction and Business Overview
7.9.3 Chopper Biology Swine Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Chopper Biology Swine Vaccines Product Offerings
7.9.5 Chopper Biology Recent Development
7.10 WINSUN
7.10.1 WINSUN Company Information
7.10.2 WINSUN Introduction and Business Overview
7.10.3 WINSUN Swine Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 WINSUN Swine Vaccines Product Offerings
7.10.5 WINSUN Recent Development
7.11 Hipra
7.11.1 Hipra Company Information
7.11.2 Hipra Introduction and Business Overview
7.11.3 Hipra Swine Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Hipra Swine Vaccines Product Offerings
7.11.5 Hipra Recent Development
7.12 Ringpu Biology
7.12.1 Ringpu Biology Company Information
7.12.2 Ringpu Biology Introduction and Business Overview
7.12.3 Ringpu Biology Swine Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 Ringpu Biology Swine Vaccines Product Offerings
7.12.5 Ringpu Biology Recent Development
7.13 ChengDu Tecbond
7.13.1 ChengDu Tecbond Company Information
7.13.2 ChengDu Tecbond Introduction and Business Overview
7.13.3 ChengDu Tecbond Swine Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
7.13.4 ChengDu Tecbond Swine Vaccines Product Offerings
7.13.5 ChengDu Tecbond Recent Development
7.14 DHN
7.14.1 DHN Company Information
7.14.2 DHN Introduction and Business Overview
7.14.3 DHN Swine Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
7.14.4 DHN Swine Vaccines Product Offerings
7.14.5 DHN Recent Development
7.15 CAVAC
7.15.1 CAVAC Company Information
7.15.2 CAVAC Introduction and Business Overview
7.15.3 CAVAC Swine Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
7.15.4 CAVAC Swine Vaccines Product Offerings
7.15.5 CAVAC Recent Development
7.16 Virbac
7.16.1 Virbac Company Information
7.16.2 Virbac Introduction and Business Overview
7.16.3 Virbac Swine Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
7.16.4 Virbac Swine Vaccines Product Offerings
7.16.5 Virbac Recent Development
7.17 HVRI
7.17.1 HVRI Company Information
7.17.2 HVRI Introduction and Business Overview
7.17.3 HVRI Swine Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
7.17.4 HVRI Swine Vaccines Product Offerings
7.17.5 HVRI Recent Development
7.18 Bioveta
7.18.1 Bioveta Company Information
7.18.2 Bioveta Introduction and Business Overview
7.18.3 Bioveta Swine Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
7.18.4 Bioveta Swine Vaccines Product Offerings
7.18.5 Bioveta Recent Development
8 Industry Chain Analysis
8.1 Swine Vaccines Industrial Chain
8.2 Swine Vaccines Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Swine Vaccines Sales Model
8.5.2 Sales Channel
8.5.3 Swine Vaccines Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Tables
 Table 1. Swine Vaccines Market Trends
 Table 2. Swine Vaccines Market Drivers & Opportunity
 Table 3. Swine Vaccines Market Challenges
 Table 4. Swine Vaccines Market Restraints
 Table 5. Global Swine Vaccines Revenue by Company (2020-2025) & (US$ Million)
 Table 6. Global Swine Vaccines Revenue Market Share by Company (2020-2025)
 Table 7. Global Swine Vaccines Sales Volume by Company (2020-2025) & (M Doses)
 Table 8. Global Swine Vaccines Sales Volume Market Share by Company (2020-2025)
 Table 9. Global Market Swine Vaccines Price by Company (2020-2025) & (USD/K Doses)
 Table 10. Key Manufacturers Swine Vaccines Manufacturing Base and Headquarters
 Table 11. Key Manufacturers Swine Vaccines Product Type
 Table 12. Key Manufacturers Time to Begin Mass Production of Swine Vaccines
 Table 13. Global Swine Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Swine Vaccines as of 2024)
 Table 15. Mergers & Acquisitions, Expansion Plans
 Table 16. Global Swine Vaccines Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
 Table 17. Global Swine Vaccines Sales Value by Type (2020-2025) & (US$ Million)
 Table 18. Global Swine Vaccines Sales Value by Type (2026-2031) & (US$ Million)
 Table 19. Global Swine Vaccines Sales Market Share in Value by Type (2020-2025)
 Table 20. Global Swine Vaccines Sales Market Share in Value by Type (2026-2031)
 Table 21. Global Swine Vaccines Sales Volume by Type: 2020 VS 2024 VS 2031 (M Doses)
 Table 22. Global Swine Vaccines Sales Volume by Type (2020-2025) & (M Doses)
 Table 23. Global Swine Vaccines Sales Volume by Type (2026-2031) & (M Doses)
 Table 24. Global Swine Vaccines Sales Market Share in Volume by Type (2020-2025)
 Table 25. Global Swine Vaccines Sales Market Share in Volume by Type (2026-2031)
 Table 26. Global Swine Vaccines Price by Type (2020-2025) & (USD/K Doses)
 Table 27. Global Swine Vaccines Price by Type (2026-2031) & (USD/K Doses)
 Table 28. Global Swine Vaccines Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
 Table 29. Global Swine Vaccines Sales Value by Application (2020-2025) & (US$ Million)
 Table 30. Global Swine Vaccines Sales Value by Application (2026-2031) & (US$ Million)
 Table 31. Global Swine Vaccines Sales Market Share in Value by Application (2020-2025)
 Table 32. Global Swine Vaccines Sales Market Share in Value by Application (2026-2031)
 Table 33. Global Swine Vaccines Sales Volume by Application: 2020 VS 2024 VS 2031 (M Doses)
 Table 34. Global Swine Vaccines Sales Volume by Application (2020-2025) & (M Doses)
 Table 35. Global Swine Vaccines Sales Volume by Application (2026-2031) & (M Doses)
 Table 36. Global Swine Vaccines Sales Market Share in Volume by Application (2020-2025)
 Table 37. Global Swine Vaccines Sales Market Share in Volume by Application (2026-2031)
 Table 38. Global Swine Vaccines Price by Application (2020-2025) & (USD/K Doses)
 Table 39. Global Swine Vaccines Price by Application (2026-2031) & (USD/K Doses)
 Table 40. Global Swine Vaccines Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
 Table 41. Global Swine Vaccines Sales Value by Region (2020-2025) & (US$ Million)
 Table 42. Global Swine Vaccines Sales Value by Region (2026-2031) & (US$ Million)
 Table 43. Global Swine Vaccines Sales Value by Region (2020-2025) & (%)
 Table 44. Global Swine Vaccines Sales Value by Region (2026-2031) & (%)
 Table 45. Global Swine Vaccines Sales Volume by Region (M Doses): 2020 VS 2024 VS 2031
 Table 46. Global Swine Vaccines Sales Volume by Region (2020-2025) & (M Doses)
 Table 47. Global Swine Vaccines Sales Volume by Region (2026-2031) & (M Doses)
 Table 48. Global Swine Vaccines Sales Volume by Region (2020-2025) & (%)
 Table 49. Global Swine Vaccines Sales Volume by Region (2026-2031) & (%)
 Table 50. Global Swine Vaccines Average Price by Region (2020-2025) & (USD/K Doses)
 Table 51. Global Swine Vaccines Average Price by Region (2026-2031) & (USD/K Doses)
 Table 52. Key Countries/Regions Swine Vaccines Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
 Table 53. Key Countries/Regions Swine Vaccines Sales Value, (2020-2025) & (US$ Million)
 Table 54. Key Countries/Regions Swine Vaccines Sales Value, (2026-2031) & (US$ Million)
 Table 55. Key Countries/Regions Swine Vaccines Sales Volume, (2020-2025) & (M Doses)
 Table 56. Key Countries/Regions Swine Vaccines Sales Volume, (2026-2031) & (M Doses)
 Table 57. Merck Company Information
 Table 58. Merck Introduction and Business Overview
 Table 59. Merck Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
 Table 60. Merck Swine Vaccines Product Offerings
 Table 61. Merck Recent Development
 Table 62. Boehringer Ingelheim Company Information
 Table 63. Boehringer Ingelheim Introduction and Business Overview
 Table 64. Boehringer Ingelheim Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
 Table 65. Boehringer Ingelheim Swine Vaccines Product Offerings
 Table 66. Boehringer Ingelheim Recent Development
 Table 67. Jinyu Bio-Technology Company Information
 Table 68. Jinyu Bio-Technology Introduction and Business Overview
 Table 69. Jinyu Bio-Technology Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
 Table 70. Jinyu Bio-Technology Swine Vaccines Product Offerings
 Table 71. Jinyu Bio-Technology Recent Development
 Table 72. CAHIC Company Information
 Table 73. CAHIC Introduction and Business Overview
 Table 74. CAHIC Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
 Table 75. CAHIC Swine Vaccines Product Offerings
 Table 76. CAHIC Recent Development
 Table 77. Tecon Company Information
 Table 78. Tecon Introduction and Business Overview
 Table 79. Tecon Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
 Table 80. Tecon Swine Vaccines Product Offerings
 Table 81. Tecon Recent Development
 Table 82. Zoetis Company Information
 Table 83. Zoetis Introduction and Business Overview
 Table 84. Zoetis Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
 Table 85. Zoetis Swine Vaccines Product Offerings
 Table 86. Zoetis Recent Development
 Table 87. Ceva Company Information
 Table 88. Ceva Introduction and Business Overview
 Table 89. Ceva Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
 Table 90. Ceva Swine Vaccines Product Offerings
 Table 91. Ceva Recent Development
 Table 92. Hile Bio Company Information
 Table 93. Hile Bio Introduction and Business Overview
 Table 94. Hile Bio Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
 Table 95. Hile Bio Swine Vaccines Product Offerings
 Table 96. Hile Bio Recent Development
 Table 97. Chopper Biology Company Information
 Table 98. Chopper Biology Introduction and Business Overview
 Table 99. Chopper Biology Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
 Table 100. Chopper Biology Swine Vaccines Product Offerings
 Table 101. Chopper Biology Recent Development
 Table 102. WINSUN Company Information
 Table 103. WINSUN Introduction and Business Overview
 Table 104. WINSUN Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
 Table 105. WINSUN Swine Vaccines Product Offerings
 Table 106. WINSUN Recent Development
 Table 107. Hipra Company Information
 Table 108. Hipra Introduction and Business Overview
 Table 109. Hipra Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
 Table 110. Hipra Swine Vaccines Product Offerings
 Table 111. Hipra Recent Development
 Table 112. Ringpu Biology Company Information
 Table 113. Ringpu Biology Introduction and Business Overview
 Table 114. Ringpu Biology Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
 Table 115. Ringpu Biology Swine Vaccines Product Offerings
 Table 116. Ringpu Biology Recent Development
 Table 117. ChengDu Tecbond Company Information
 Table 118. ChengDu Tecbond Introduction and Business Overview
 Table 119. ChengDu Tecbond Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
 Table 120. ChengDu Tecbond Swine Vaccines Product Offerings
 Table 121. ChengDu Tecbond Recent Development
 Table 122. DHN Company Information
 Table 123. DHN Introduction and Business Overview
 Table 124. DHN Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
 Table 125. DHN Swine Vaccines Product Offerings
 Table 126. DHN Recent Development
 Table 127. CAVAC Company Information
 Table 128. CAVAC Introduction and Business Overview
 Table 129. CAVAC Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
 Table 130. CAVAC Swine Vaccines Product Offerings
 Table 131. CAVAC Recent Development
 Table 132. Virbac Company Information
 Table 133. Virbac Introduction and Business Overview
 Table 134. Virbac Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
 Table 135. Virbac Swine Vaccines Product Offerings
 Table 136. Virbac Recent Development
 Table 137. HVRI Company Information
 Table 138. HVRI Introduction and Business Overview
 Table 139. HVRI Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
 Table 140. HVRI Swine Vaccines Product Offerings
 Table 141. HVRI Recent Development
 Table 142. Bioveta Company Information
 Table 143. Bioveta Introduction and Business Overview
 Table 144. Bioveta Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
 Table 145. Bioveta Swine Vaccines Product Offerings
 Table 146. Bioveta Recent Development
 Table 147. Key Raw Materials Lists
 Table 148. Raw Materials Key Suppliers Lists
 Table 149. Swine Vaccines Downstream Customers
 Table 150. Swine Vaccines Distributors List
 Table 151. Research Programs/Design for This Report
 Table 152. Key Data Information from Secondary Sources
 Table 153. Key Data Information from Primary Sources


List of Figures
 Figure 1. Swine Vaccines Product Picture
 Figure 2. Global Swine Vaccines Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Global Swine Vaccines Sales Value (2020-2031) & (US$ Million)
 Figure 4. Global Swine Vaccines Sales Volume (2020-2031) & (M Doses)
 Figure 5. Global Swine Vaccines Sales Price (2020-2031) & (USD/K Doses)
 Figure 6. Swine Vaccines Report Years Considered
 Figure 7. Global Swine Vaccines Players Revenue Ranking (2024) & (US$ Million)
 Figure 8. Global Swine Vaccines Players Sales Volume Ranking (2024) & (M Doses)
 Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Swine Vaccines Revenue in 2024
 Figure 10. Swine Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 11. CSF Vaccines Picture
 Figure 12. FMD Vaccines Picture
 Figure 13. Porcine Circovirus Vaccines Picture
 Figure 14. PRRS Vaccines Picture
 Figure 15. Others Picture
 Figure 16. Global Swine Vaccines Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 17. Global Swine Vaccines Sales Value Market Share by Type, 2024 & 2031
 Figure 18. Global Swine Vaccines Sales Volume by Type (2020 VS 2024 VS 2031) & (M Doses)
 Figure 19. Global Swine Vaccines Sales Volume Market Share by Type, 2024 & 2031
 Figure 20. Global Swine Vaccines Price by Type (2020-2031) & (USD/K Doses)
 Figure 21. Product Picture of Government Tender
 Figure 22. Product Picture of Market Sales
 Figure 23. Global Swine Vaccines Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 24. Global Swine Vaccines Sales Value Market Share by Application, 2024 & 2031
 Figure 25. Global Swine Vaccines Sales Volume by Application (2020 VS 2024 VS 2031) & (M Doses)
 Figure 26. Global Swine Vaccines Sales Volume Market Share by Application, 2024 & 2031
 Figure 27. Global Swine Vaccines Price by Application (2020-2031) & (USD/K Doses)
 Figure 28. North America Swine Vaccines Sales Value (2020-2031) & (US$ Million)
 Figure 29. North America Swine Vaccines Sales Value by Country (%), 2024 VS 2031
 Figure 30. Europe Swine Vaccines Sales Value, (2020-2031) & (US$ Million)
 Figure 31. Europe Swine Vaccines Sales Value by Country (%), 2024 VS 2031
 Figure 32. Asia Pacific Swine Vaccines Sales Value, (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Swine Vaccines Sales Value by Region (%), 2024 VS 2031
 Figure 34. South America Swine Vaccines Sales Value, (2020-2031) & (US$ Million)
 Figure 35. South America Swine Vaccines Sales Value by Country (%), 2024 VS 2031
 Figure 36. Middle East & Africa Swine Vaccines Sales Value, (2020-2031) & (US$ Million)
 Figure 37. Middle East & Africa Swine Vaccines Sales Value by Country (%), 2024 VS 2031
 Figure 38. Key Countries/Regions Swine Vaccines Sales Value (%), (2020-2031)
 Figure 39. Key Countries/Regions Swine Vaccines Sales Volume (%), (2020-2031)
 Figure 40. United States Swine Vaccines Sales Value, (2020-2031) & (US$ Million)
 Figure 41. United States Swine Vaccines Sales Value by Type (%), 2024 VS 2031
 Figure 42. United States Swine Vaccines Sales Value by Application (%), 2024 VS 2031
 Figure 43. Europe Swine Vaccines Sales Value, (2020-2031) & (US$ Million)
 Figure 44. Europe Swine Vaccines Sales Value by Type (%), 2024 VS 2031
 Figure 45. Europe Swine Vaccines Sales Value by Application (%), 2024 VS 2031
 Figure 46. China Swine Vaccines Sales Value, (2020-2031) & (US$ Million)
 Figure 47. China Swine Vaccines Sales Value by Type (%), 2024 VS 2031
 Figure 48. China Swine Vaccines Sales Value by Application (%), 2024 VS 2031
 Figure 49. Japan Swine Vaccines Sales Value, (2020-2031) & (US$ Million)
 Figure 50. Japan Swine Vaccines Sales Value by Type (%), 2024 VS 2031
 Figure 51. Japan Swine Vaccines Sales Value by Application (%), 2024 VS 2031
 Figure 52. South Korea Swine Vaccines Sales Value, (2020-2031) & (US$ Million)
 Figure 53. South Korea Swine Vaccines Sales Value by Type (%), 2024 VS 2031
 Figure 54. South Korea Swine Vaccines Sales Value by Application (%), 2024 VS 2031
 Figure 55. Southeast Asia Swine Vaccines Sales Value, (2020-2031) & (US$ Million)
 Figure 56. Southeast Asia Swine Vaccines Sales Value by Type (%), 2024 VS 2031
 Figure 57. Southeast Asia Swine Vaccines Sales Value by Application (%), 2024 VS 2031
 Figure 58. India Swine Vaccines Sales Value, (2020-2031) & (US$ Million)
 Figure 59. India Swine Vaccines Sales Value by Type (%), 2024 VS 2031
 Figure 60. India Swine Vaccines Sales Value by Application (%), 2024 VS 2031
 Figure 61. Swine Vaccines Industrial Chain
 Figure 62. Swine Vaccines Manufacturing Cost Structure
 Figure 63. Channels of Distribution (Direct Sales, and Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD